HAVCR2 and bone sarcoma: These results are in line with previous studies on TIM-3 in soft tissue and bone sarcomas: Ligon et al. analyzed tumor-infiltrating lymphocytes in osteosarcoma pulmonary metastases and compared them with primary bone tumors.